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Dengue serotype 3 viruses were isolated from patients 
in Brazil from 2002 through 2004. On the basis of phyloge-
netic analyses, these isolates were assigned genotype 1. 
This genotype had never been reported in South America 
before. Its appearance indicates a major risk factor for den-
gue epidemics and severe disease. 
C
urrently, dengue is the most signiﬁ  cant  mosquito-
borne viral disease that affects humans. Dengue virus 
(DENV) is transmitted to humans by Aedes aegypti mos-
quitoes; for most persons, this infection is either asymp-
tomatic or dengue fever (DF) develops. In a few cases, DF 
can progress to life-threatening dengue hemorrhagic fever/
dengue shock syndrome (DHF/DSS). Epidemiologic and 
phylogenetic studies indicate that particular DENV strains 
are more virulent than others (1,2). DENV comprises 4 
serotypes. Phylogenetic and molecular analyses showed 
extensive variability among the DENV serotypes, which 
led to the recognition of different genotypes within each 
serotype. For DENV-1 and DENV-2, ﬁ  ve genotypes have 
been described (2); DENV-3 and DENV-4 have been sub-
divided into 4 and 2 genotypes, respectively (3,4). Regard-
ing DENV-3, genotype 1 includes isolates from Southeast 
Asia and the South Paciﬁ  c islands; genotype 2, Thailand; 
genotype 3, the Indian subcontinent, East Africa, and a sin-
gle isolate from Samoa; and genotype 4, Puerto Rico and 
Tahiti (3).
Since 2000, DENV-1, DENV-2, and DENV-3 have 
been found cocirculating in 22 of the 27 states in Brazil 
(5,6). DENV-3 in Brazil belongs to genotype 3 and includes 
strains from Sri Lanka, India, and Africa (6–8). Since 1996, 
successive epidemics have been occurring in the city of 
Belo Horizonte (estimated population 2,214,000), which is 
located in the south-central region of Minas Gerais State, 
Brazil. Of the 700,000 dengue cases reported in Latin 
America in 1998, 12.4% were from Belo Horizonte, and 
58.8% were from Minas Gerais State, respectively (9). Be-
sides DENV-1 and DENV-2, the DENV-3 serotype was 
also detected in Minas Gerais State, but only a few DENV-
3 isolates have been analyzed with respect to their genetic 
variability. 
The Study
We analyzed the C-prM and the envelope genes of 
DENV-3 isolates related to different clinical manifesta-
tions of dengue disease from Minas Gerais State, Brazil, 
from 2002 through 2004. Nine acute-phase serum samples 
from patients with DF or DHF (previously identiﬁ  ed by 
PCR as DENV-3) were selected for this study (Table). All 
serum samples were from patients living in the city of Belo 
Horizonte or neighboring cities (Figure 1). Only 1 case-pa-
tient (patient MG-20) died. 
For viral isolation, 50 μL of each serum sample was in-
cubated with C6/36 cells, and at least 3 successive passages 
were conducted for each sample. Microscopic examination 
of cells inoculated with serum from the patients showed a 
clearly visible cytopathic effect with changes in the mono-
layer such as syncytial cell formation and cytoplasmic vac-
uoles after the third passage (data not shown). 
Supernatants of infected C6/36 cells showing typi-
cal cytopathic effect were used for viral RNA extraction 
(QIAamp Viral RNA Kit, QIAGEN, Inc., Valencia, CA, 
USA). RNA was used as template in reverse transcription– 
PCR (RT-PCR), as described (10).
For determination of nucleotide sequences in the C-
prM region from 9 virus samples, the amplicons were 
cloned into a pGEM-T vector (Promega Corp., Madison, 
WI, USA), and 3 clones for each isolate were used in se-
quencing reactions. To determine the nucleotide sequence 
of the envelope gene from 4 isolates, we puriﬁ  ed PCR 
amplicons (QIAquick Gel Extraction Kit, QIAGEN) and 
directly used in sequencing reactions. Each DNA sample 
was sequenced at least 3 times in both orientations (Mega-
BACE sequencer, GE Healthcare, Buckinghamshire, UK). 
Nucleotide sequences were aligned with other DENV-3 
sequences. The midpoint rooted phylogenetic trees were 
constructed by the neighbor-joining method with 1,000 
bootstrap replicates using the Tamura Nei model imple-
mented by the software MEGA 3.1 (Arizona State Univer-
sity, Phoenix, AZ, USA). 
Sequence comparisons showed high degrees of identity 
among our isolates, and the paired identity at the nucleotide 
level ranged from 99.2% to 100% and from 99.7% to 99.9% 
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regarding the C-prM region and the envelope gene, respec-
tively. When sequences were compared with genotype 3 
isolates, including isolates from Latin America, the Indian 
subcontinent, and East Africa, the identity values ranged 
from 95.4% to 96.2% and from 94.0 to 95.6% in relation to 
the C-prM and envelope genes, respectively. When those 
were compared to genotype 1 sequences from the Philip-
pines and China, the nucleotide identities of C-prM region 
ranged from 98.4% to 99.4%; when envelope sequences 
were analyzed, values from 99.1% to 99.5% nucleotide 
identity were observed. According to phylogenetic cluster-
ing with other DENV strains (Figure 2), viruses were clas-
siﬁ  ed into a speciﬁ  c serotype and genotype. Both phyloge-
netic trees showed isolates from Brazil grouped together in 
a well-supported distinct cluster of genotype 1 isolates.
 Conclusions
Various genomic regions of DENV have been used for 
molecular phylogenetic analyses. As described (10,11), the 
C-prM junction and envelope genes have been used as the 
most sensitive method for virus detection because they har-
bor epidemiologically relevant sequence information. 
Although consensus nucleotide sequences of DENV 
isolated from different localities have provided some mea-
sure of genetic diversity, only a small number of studies 
use viruses isolated from the same location. Moreover, 
phylogenetic studies indicated an association between spe-
ciﬁ  c genotype and the severity of the disease (8,12). 
By analyzing a conserved region of the DENV genome 
(504 nt of C-prM gene) and a more variable region (1,023 
nt of the envelope gene), we veriﬁ  ed that the DENV-3 iso-
lates belong to genotype 1 (Figure 2). Other DENV-3 iso-
lates sampled from Rio de Janeiro, Brazil, from 2001 to 
2002 during an outbreak and also in Latin America were 
assigned to genotype 3, which has been associated with 
DHF outbreaks (6–8,13).
Phylogenetic studies have shown that DENV can move 
long distances between continents as well as short distanc-
es between neighboring countries (8,14). In this study, all 
DENV-3 isolates, which were associated with DF, DHF, 
and a fatal case, belonged to genotype 1. However, no con-
sistent differences among the isolates in relation to C-prM 
or envelope sequences were found to be associated with 
distinct clinical outcomes nor did they form phylogeneti-
cally distinct groups. If the disease severity in DENV-3–in-
fected patients does have a genetic basis, it cannot be at-
tributed to the C-prM or envelope gene.
DENV-3 genotype 1 in Minas Gerais State is more 
likely to be imported from Asia because these isolates were 
closely related in the phylogenetic tree to the reference 
strain from the Philippines and China (15). It is difﬁ  cult to 
determine the precise route of importation of DENV into 
Minas Gerais because the available data are limited. But 
one could speculate that the introduction of genotype 1 
into Minas Gerais occurred in 2002, because this genotype 
had not been detected in that area before 2002. This study 
shows the emergence of a new DENV-3 genotype not only 
in Minas Gerais, but in the entire subcontinent, which is a 
matter for prospective public health studies. 
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Table. Description of the dengue virus serotype 3 isolates*  
GenBank accession nos. 




age, y  City Year 
Passage
history†  E sequence  C-prM sequence 
BH–16 DF(HM) M 42 Belo  Horizonte  2003 5 EF625832 EF428575
BH–17 DF(HM) M 6 Belo  Horizonte 2003 4 EF428567
BH–19 DF M 29 Belo Horizonte  2003 5 EF625833 EF428574
MG–20‡ DHF F 18 Contagem 2004 4 EF625835 EF428572
MG–21 DF F 37 Sabará 2003 5 EF428568
BH–22 DHF F 11 Belo Horizonte  2004 5 EF428571
BH–24 DF F 37 Belo Horizonte  2003 6 EF625834 EF428570
BH–25 DF M 25 Belo Horizonte  2003 3 EF428569
MG–27 DF –  –  Caetanopólis 2002 6 EF428573
*DF, dengue fever; DF(HM), dengue fever with hemorrhagic manifestations; DHF, dengue hemorrhagic fever, according to World Health Organization 
definition; –, data not available. 
†Number of passages in cell culture (C6/36 cell line) is shown. 
‡Fatal case. 
Figure 1. Location of the city of Belo Horizonte and its boroughs 
Pampulha, Nordeste, and Noroeste, Minas Gerais State, where 
samples of  dengue virus serotype 3 viruses were collected during 
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Figure 2. Phylogenetic trees of established dengue virus serotype 3 
(DENV-3) and new sequences from Minas Gerais State, Brazil, 
identiﬁ  ed in this study. A) The tree is based on a 504-nt sequence 
alignment comprising the C-prM gene (nucleotides 137–638). B) 
The tree is based on a 1,023-nt partial E nucleotide sequences 
(nucleotides 1022–2008). This tree was generated by neighbor-
joining using the Tamura Nei model implemented by using MEGA3 
software (www.megasoftware.net). Numbers to the left of nodes 
represent bootstrap values (1,000 replicates) in support of grouping 
to the right. Numbers to the right in parentheses of branches 
indicate the GenBank accession number. Roman numerals denote 
the different genotypes of DENV-3.